POSB158 Cost-Effectiveness of Obinutuzumab Combined with Chemotherapy As Induction Therapy and Followed By Obinutuzumab Maintenance Therapy for Treatment Naïve Patients with Advanced Follicular Lymphoma in Mainland China
Abstract
Authors
Q Gong H Gu A Launonen X Ran Y Xia W Chen